References
- Burstein R, Jakubowski M. A unitary hypothesis for multiple triggers of the pain and strain of migraine. J. Comp. Neurol.493, 9–14 (2005).
- Smith T, Banks J, Nicholson R. ‘Is a triptan the first headache medication you take?’ How order of use differentiates migraine sufferers’ triptan adherence and quality of life. Headache47, 755 (2007).
- Levy D, Kakubowski M, Burstein R. Disruption of communication between peripheral and central trigeminovascular neurons by a 5HT1B/1D agonist: implications for migraine therapy with triptans. Proc. Natl Acad. Sci. USA101, 4274–4279 (2004).
- Jakubowski M, Levy D, Goor-Aryeh I, Collins B, Bajwa Z, Burstein R. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors. Headache45, 850–861 (2005).
- Silberstein SD, Winner PK, Chmiel JJ. Migraine preventative medication reduces resource utilization. Headache43, 171–178 (2003).
- Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache41, 646–657 (2001).
- Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States: epidemiology and patterns of health care use. Neurology58, 885–894 (2002).
- Evans RW. The FDA alert on serotonin syndrome with combined use of SSRIs or SNRIs and triptans: an analysis of the 29 case reports. Medscape9, 48 (2007).
- Tepper S, Allen C, Sanders D, Greene A, Boccuzzi S. Coprescription of triptans with potentially interacting medications: a cohort study involving 240,268 patients. Headache43, 44–48 (2003)
- Shapiro R, Tepper S. The serotonin syndrome, triptans, and the potential for drug-drug interactions. Headache47, 266–269 (2007).
- Mackay FJ, Dunn NR, Mann RD. Antidepressants and the serotonin syndrome in general practice. Br. J. Gen. Pract.49, 871–874 (1999).
Website
- Ramadan NM, Silberstein SD, Freitag FG, Gilbert TT, Frishberg BM. Evidence-Based Guidelines for Migraine Headache in the Primary Care Setting: Pharmacological Management for Prevention of Migraine http://aan.com/professionals/practice/pdfs/gl0090.pdf